Cargando…

Multiple positron emission tomography tracers for use in the classification of gliomas according to the 2016 World Health Organization criteria

BACKGROUND: The molecular diagnosis of gliomas such as isocitrate dehydrogenase (IDH) status (wild-type [wt] or mutation [mut]) is especially important in the 2016 World Health Organization (WHO) classification. Positron emission tomography (PET) has afforded molecular and metabolic diagnostic imagi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyake, Keisuke, Suzuki, Kenta, Ogawa, Tomoya, Ogawa, Daisuke, Hatakeyama, Tetsuhiro, Shinomiya, Aya, Kudomi, Nobuyuki, Yamamoto, Yuka, Nishiyama, Yoshihiro, Tamiya, Takashi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920529/ https://www.ncbi.nlm.nih.gov/pubmed/33681765 http://dx.doi.org/10.1093/noajnl/vdaa172

Ejemplares similares

NI-08 Utility of multiple positron emission tomography tracers in the diagnosis of brain tumors according to the 2016 World Health Organization classification
por: Miyake, Keisuke, et al.
Publicado: (2020)

Diagnostic value of PET/CT with (11)C-methionine (MET) and (18)F-fluorothymidine (FLT) in newly diagnosed glioma based on the 2016 WHO classification
por: Ogawa, Tomoya, et al.
Publicado: (2020)

Hypoxia and glucose metabolism assessed by FMISO and FDG PET for predicting IDH1 mutation and 1p/19q codeletion status in newly diagnosed malignant gliomas
por: Suzuki, Kenta, et al.
Publicado: (2021)

BIMG-06. RESPONSE ASSESSMENT OF BEVACIZUMAB THERAPY FOR GLIOBLASTOMA BY USING MULTIPLE PET TRACERS
por: Miyake, Keisuke, et al.
Publicado: (2021)

Usefulness of Positron Emission Tomographic Studies for Gliomas
por: MIYAKE, Keisuke, et al.
Publicado: (2016)

Fractal analysis of (11)C-methionine PET in patients with newly diagnosed glioma
por: Maeda, Yukito, et al.
Publicado: (2021)

Usefulness of FDG, MET and FLT-PET Studies for the Management of Human Gliomas
por: Miyake, Keisuke, et al.
Publicado: (2012)

Temporal and spatial changes in reactive astrogliosis examined by (18)F-THK5351 positron emission tomography in a patient with severe traumatic brain injury
por: Hatakeyama, Tetsuhiro, et al.
Publicado: (2021)

Comparison of 4′-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3′-deoxy-3′-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging
por: Toyota, Yasunori, et al.
Publicado: (2015)

STMO-15 OUR THERAPEUTIC STRATEGIES FOR GLIOBLASTOMA: INTRAOPERATIVE SUPPORT SYSTEMS [INTRAOPERATIVE MRI, PET, 5-AMINOLEVULINIC ACID (5-ALA)] AND NEOADJUVANT CHEMOTHERAPY
por: Miyake, Keisuke, et al.
Publicado: (2019)

IMG-02. USEFUL DIAGNOSIS OF PEDIATRIC CYSTIC BRAIN TUMORS USING MULTIPLE POSITRON EMISSION TOMOGRAPHY STUDIES
por: Miyake, Keisuke, et al.
Publicado: (2020)

Diagnostic Value of (11)C-Methionine (MET) and (18)F-Fluorothymidine (FLT) Positron Emission Tomography in Recurrent High-Grade Gliomas; Differentiation from Treatment-Induced Tissue Necrosis
por: Shishido, Hajime, et al.
Publicado: (2012)

NI-15 THE USEFULNESS OF PET IMAGING IN MOLECULAR DIAGNOSIS OF GLIOMA
por: Ogawa, Tomoya, et al.
Publicado: (2019)

(18)F-FDG PET in the Diagnosis and Treatment of Primary Central Nervous System Lymphoma
por: Kawai, Nobuyuki, et al.
Publicado: (2013)

STMO-5 Utilization of intraoperative multimodal technologies [PET and 5-ALA] for treating glioblastoma
por: Miyake, Keisuke, et al.
Publicado: (2021)

GEN-09 Pursuing the function of microRNA targeting (Pro)renin receptor against glioma
por: Ogawa, Daisuke, et al.
Publicado: (2020)

Clinicopathologic Factors Associated with Tumor Necrosis after Preoperative Embolization of Meningiomas
por: Fujimori, Takeshi, et al.
Publicado: (2021)

Correlation of 4′-[methyl-(11)C]-thiothymidine PET with Gd-enhanced and FLAIR MRI in patients with newly diagnosed glioma
por: Norikane, Takashi, et al.
Publicado: (2021)

Imaging of the appearance time of cerebral blood using [(15)O]H(2)O PET for the computation of correct CBF
por: Kudomi, Nobuyuki, et al.
Publicado: (2013)

Applicability of emission-based attenuation map for rapid CBF, OEF, and CMRO(2) measurements using gaseous (15)O-labeled compounds
por: Maeda, Yukito, et al.
Publicado: (2015)

ET-04 MOLECULAR TARGETED THERAPY AGAINST (PRO)RENIN RECEPTOR FOR GLIOBLASTOMA
por: Fujimori, Takeshi, et al.
Publicado: (2019)

Effects of a monoclonal antibody against (pro)renin receptor on gliomagenesis
por: Fujimori, Takeshi, et al.
Publicado: (2023)

Effect of quantitative values on shortened acquisition duration in brain tumor (11)C-methionine PET/CT
por: Morimoto, Masatoshi, et al.
Publicado: (2021)

Insufficiency of Positron Emission Tomography and Magnetic Resonance Spectroscopy in the Diagnosis of Intravascular Lymphoma of the Central Nervous System
por: Kawai, Nobuyuki, et al.
Publicado: (2012)

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (6), assessment of mandibular metabolism due to long-term administration of an anti-resorptive agent by bone scintigraphy (secondary publication)()()
por: Ohbayashi, Yumiko, et al.
Publicado: (2019)

Tau Filaments and the Development of Positron Emission Tomography Tracers
por: Goedert, Michel, et al.
Publicado: (2018)

Antiproliferative effects of D-allose associated with reduced cell division frequency in glioblastoma
por: Suzuki, Kenta, et al.
Publicado: (2023)

Rapid quantitative CBF and CMRO(2) measurements from a single PET scan with sequential administration of dual (15)O-labeled tracers
por: Kudomi, Nobuyuki, et al.
Publicado: (2013)

First-in-class positron emission tomography tracer for the glucagon receptor
por: Velikyan, Irina, et al.
Publicado: (2019)

Novel Positron Emission Tomography Tracers for Imaging Vascular Inflammation
por: Ćorović, Andrej, et al.
Publicado: (2020)

Texture indices of 4′-[methyl-(11)C]-thiothymidine uptake predict p16 status in patients with newly diagnosed oropharyngeal squamous cell carcinoma: comparison with (18)F-FDG uptake
por: Ihara-Nishishita, Ayumi, et al.
Publicado: (2020)

New evidence of arsenic translocation and accumulation in Pteris vittata from real-time imaging using positron-emitting (74)As tracer
por: Kohda, Yi Huang-Takeshi, et al.
Publicado: (2021)

CBMS-12 Pro renin receptor antibody regulates glioblastoma stemness
por: Fujimori, Takeshi, et al.
Publicado: (2020)

ANGI-1 ASSESSING THE THERAPEUTIC EFFECT OF BEVACIZUMAB USING FMISO-PET IN GBM THERAPY
por: Suzuki, Tomoya, et al.
Publicado: (2022)

Recent Developments in Positron Emission Tomography Tracers for Proteinopathies Imaging in Dementia
por: Ni, Ruiqing, et al.
Publicado: (2022)

Tracers progress for positron emission tomography imaging of glial-related disease
por: Jia, Haoran, et al.
Publicado: (2022)

Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients
por: Tsuboi, Hiroto, et al.
Publicado: (2017)

Compelling Case for Fostering Titanium-45 for Positron Emission Tomography Tracer Applications
por: Ramamoorthy, Natesan
Publicado: (2020)

Contribution of Different Positron Emission Tomography Tracers in Glioma Management: Focus on Glioblastoma
por: Moreau, Aurélie, et al.
Publicado: (2019)

Precise quantitative evaluation of pharmacokinetics of cisplatin using a radio-platinum tracer in tumor-bearing mice
por: Obata, Honoka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8sqkgnflv4pam7bujnh2rs4gip